Xoma reported $0 in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agios Pharmaceuticals AGIO:US $ 0.41M 0.59M
Ardelyx ARDX:US $ 51.48M 0.23M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Celldex Therapeutics CLDX:US $ 0M 0M
Chimerix CMRX:US $ 14M 0M
Curis CRIS:US $ 0M 0M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Emergent Biosolutions EBS:US $ 848.9M 5.1M
Epizyme EPZM:US $ 231.84M 0.64M
Intercept Pharmaceuticals ICPT:US $ 530.4M 45.42M
Life Technologies LIFE:US $ 0M 0M
Macrogenics MGNX:US $ 0M 0M
Novartis NOVN:VX SF 34243M 1526M
Novartis NVS:US $ 34243M 1526M
Prothena PRTA:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 2698.6M 1M
Teva Pharmaceutical Industries TEVA:US $ 23746M 1386M
Xoma XOMA:US $ 0 0
YTE INCY:US $ 33.78M 0.47M